 |
|
|
| |
Rapid Reductions of HDV RNA and ALT with the Monoclonal Antibody, BJT-778: Results from a Phase 2 Study
|
| |
| |
EASL 2024 June 5-8 Milan italy
Kosh Agarwal1, Marta Dobryanska2, Alina Jucov3, Patrick Kennedy4, Edward J. Gane5, Man-FungYuen6, Grace Lai-Hung Wong7, Simone Strasser8, Jacinta Holmes9, Stuart Roberts10, Hassan Javanbakht11, Nancy Shulman11
Kings College Hospital, London, UK. 2ARENSIA Exp Med, Kyiv, UA. 3ARENSIA Exp Med, Chisinau, MD. 4Queen Mary Hospital, London, UK. 5New Zealand Clinical Research, Auckland, NZ. 6Queen Mary Hospital, HK. 7Prince of Wales Hospital, HK. 8Royal Prince Alfred Hospital, Sydney, AUS. 9St. Vincent's Hospital, Melbourne, AUS. 10The Alfred Hospital, Melbourne, AUS. 11Bluejay Therapeutics, Inc., San Mateo, US.
|
| |
|
|
|
|
|
